4.73

0.63% -0.03

Edesa Biotech Inc (EDSA)

Overview News Price History Financials Discussions Forecast Stock Split

Edesa Biotech Inc stock is traded at $4.73, with a volume of 36,330. It is down -0.63% in the last 24 hours and down -11.75% over the past month. Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Previous Close:

$4.76

Open:

$4.72

24h Volume:

36,330

Relative Volume:

0.23

Market Cap:

$45.60M

Revenue:

Net Income/Loss:

$-10.44M

P/E Ratio:

-3.5283

EPS:

-1.3406

Net Cash Flow:

$-7.72M

1W Performance:

+2.38%

1M Performance:

-11.75%

6M Performance:

+10.77%

1Y Performance:

+86.96%

1-Day Range:

$4.72

$4.969

1-Week Range:

$4.45

$5.0532

52-Week Range:

$0.72

$20.32

Edesa Biotech Inc Stock (EDSA) Company Profile

Name

Edesa Biotech Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(905) 475-1234

Address

100 SPY COURT, MARKHAM, ON

Employee

Twitter

@EdesaBiotech

Next Earnings Date

2026-08-14

Latest SEC Filings

EDSA's Discussions on Twitter

Compare EDSA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EDSA Edesa Biotech Inc	4.73	45.89M	0	-10.44M	-7.72M	-1.3406
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Edesa Biotech Inc Stock (EDSA) Latest News

Aug 20, 2026

Edesa Biotech Enters Underwriting Deal With Guggenheim for $23.1M Equity Offering - TradingView

Aug 20, 2026

EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits

Aug 20, 2026

Edesa Biotech Prices $25 Million Stock-and-Warrant Offering to Fund Drug Pipeline - finance.biggo.com

Aug 20, 2026

Edesa Biotech Shares Tumble 13% on $25 Million Equity Offering - finance.biggo.com

Aug 20, 2026

Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits

Aug 20, 2026

Edesa (EDSA) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session; Share Move - vinanet.vn

Aug 20, 2026

Edesa Biotech Stock Sinks After Fresh Capital Raise - TradingView

Aug 20, 2026

Edesa Biotech raises USD 25m to fuel vitiligo Phase II - AllSci

Aug 20, 2026

Aug 19, 2026

Edesa Biotech prices $25M public offering at $5.50 per share By Investing.com - Investing.com Australia

Aug 19, 2026

Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com Australia

Aug 19, 2026

Edesa Biotech Announces Pricing of $25.0 Million Public Offering - Yahoo Finance

Aug 19, 2026

Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com Nigeria

Aug 19, 2026

Edesa Biotech Launches Public Offering of Common Shares, Warrants - marketscreener.com

Aug 19, 2026

Edesa Biotech Launches Public Offering to Fund Immuno-Inflammatory Pipeline - TipRanks

Aug 19, 2026

Edesa Biotech launches public offering of common shares - Investing.com

Aug 19, 2026

Edesa Biotech stock tumbles on public offering launch - Investing.com

Aug 19, 2026

Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants - Quiver Quantitative

Aug 19, 2026

Edesa Biotech Announces Proposed Public Offering - The Manila Times

Aug 19, 2026

Edesa Biotech(EDSA) Stock Options Chain | Quotes & News - Moomoo

Aug 19, 2026

Aug 18, 2026

Edesa Biotech Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Aug 18, 2026

EDSA Q2 2026 Earnings: EPS Misses Consensus by 84.77% Despite Shares Rallying 5.61%Earnings Volatility Report - vinanet.vn

Aug 18, 2026

Brokers Set Expectations for Edesa Biotech FY2026 Earnings - MarketBeat

Aug 18, 2026

Aug 16, 2026

EDSA Q2 2026 Earnings: Wider-than-Expected Loss Amid Clinical-Stage SpendingShare Dilution Risk - vinanet.vn

Aug 16, 2026

Aug 14, 2026

EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits

Aug 14, 2026

Aug 13, 2026

Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat

Aug 13, 2026

Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Form 8K EDESA BIOTECH For: 13 August By Investing.com - Investing.com South Africa

Aug 13, 2026

Edesa Biotech Q3 loss widens 140% to $5.4M on rising R&D spend - scanx.trade

Aug 13, 2026

Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens - Stock Titan

Aug 13, 2026

Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins - Quiver Quantitative

Aug 13, 2026

Edesa Starts Activating First Vitiligo Trial Sites as Enrollment Nears - Stock Titan

Aug 13, 2026

Aug 11, 2026

Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView

Aug 11, 2026

Edesa Biotech (EDSA) Rallies 5.34% as Shares Test Key Resistance at $5.80Support Level Bounce - dars.gov.et

Aug 11, 2026

Aug 10, 2026

Edesa Biotech (EDSA) Edges Up 2.28% to $5.39 as Clinical-Stage Biotech Draws InterestStop Run - dars.gov.et

Aug 10, 2026

Aug 09, 2026

Edesa Biotech (EDSA) to Post Earnings on Monday - MarketBeat

Aug 09, 2026

Aug 07, 2026